YungKhai
2021-06-30

$Histogenics(OCGN)$

Moving another step closer to World Health Organisation (WHO) approval, the rolling data of ‘made in India’ Covid-19 vaccine Covaxin will be starting in July. This has come after the pre-submission meeting held on June 23 with Bharat Biotech.

The status of Covid-19 vaccines within the EUL/PQ (emergency use listing/prequalification) evaluation process was updated on Tuesday by WHO in its latest guidance document.

Emergency Use Listing (EUL) is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies, WHO guidelines said.

Stating that its Covid-19 vaccine Covaxin adheres to international standards, Bharat Biotech’s joint managing director Suchitra Ella on Tuesday said external timelines are in the company’s hands.

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

发表看法
2